Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children
- 896 Downloads
Persistent trimethylaminuria in children is caused by autosomal recessively inherited impairment of hepatic trimethylamine (TMA) oxidation due to deficiency of flavin monooxygenase 3 (FMO3) secondary to mutations in the FMO3 gene. Trimethylaminuria or ‘fish odour syndrome’ is due to excessive excretion into body fluids and breath of TMA derived from the enterobacterial metabolism of dietary precursors. The disorder is present from birth but becomes apparent as foods containing high amounts of choline or of trimethylamine N-oxide (TMAO) from marine (sea or saltwater) fish are introduced into the diet. In our experience, trimethylaminuria (FMO3 deficiency) in children is rare. We have compared the dynamics and diagnostic efficacy of choline loading with marine fish meals in six children with trimethylaminuria. Loading with a marine fish meal provides a simple and acceptable method for confirmation of diagnosis of suspected trimethylaminuria in children, with the effects being cleared more quickly than with a choline load test. However, oral loading with choline bitartrate allows estimation of residual oxidative capacity in vivo and is a useful adjunct to molecular studies. Patients homozygous for the ‘common’ P153L mutation in the FMO3 gene showed virtual complete lack of residual TMA N-oxidative capacity, consistent with a nonfunctional or absent FMO3 enzyme, whereas a patient with the M82T mutation showed some residual oxidative capacity. A patient compound heterozygous for two novel mutations, G193E and R483T, showed considerable residual N-oxidative capacity. A further patient, heterozygous for two novel sequence variations in the FMO3 gene, consistently showed malodour and elevated urinary TMA/TMAO ratios under basal conditions but a negative response to both choline and marine fish meal loading. Comparison of the effects of administration of antibiotics (metronidazole, amoxicillin, neomycin) on gut bacterial production of trimethylamine from choline showed they all reduced TMA production to a limited extent, with neomycin being most effective. ‘Best-practice’ diagnostic and treatment guidelines are summarized.
KeywordsCholine Trimethylamine TMAO M82T Mutation P153L Mutation
Unable to display preview. Download preview PDF.
- Ackerman BR, Lemass H, Chow LML, et al (1999) Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort. Mol Genet Metab 68: 24–31.Google Scholar
- Ayesh R, Mitchell SC, Zhang A, Smith RL (1993) The fish odour syndrome: biochemical, familial, and clinical aspects. Br Med J 307: 655–657.Google Scholar
- Boriello SP, Reed PJ, Bain MD, et al (1987) The possible role of anaerobes in methylmalonic aciduria—an inherited metabolic disease. In: Drasar BS, Duerden BI, Hudson MJ, Lysons RJ, eds. Recent Advances in Anaerobic Bacteriology. Dordrecht: Matinus Nijhoff, 319–321.Google Scholar
- Chalmers RA, Bain MD, Iles RA (2003) Diagnosis of trimethylaminuria in children: marine fish versus choline load test. J Inherit Metab Dis 26(supplement 2): 224.Google Scholar
- Fraser-Andrews EA, Manning NJ, Ashton GHS, Eldridge P, McGrath JA, Menagé H du P (2003) Fish odour syndrome with features of both primary and secondary trimethylaminuria. Clin Exp Dermatol 28: 203–205.Google Scholar
- Murphy HC, Dolphin CT, Janmohamed A, et al (2000) A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy. Phamacogenetics 10: 439–451.Google Scholar
- Spellacy E, Watts RWE, Goolamali SK (1979) Trimethylaminuria. J Inherit Metab Dis 2: 85–88.Google Scholar